Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

0.8535

+0.0103 (1.22%)

At close: May 6, 2026, 4:00 PM EDT

0.8335

-0.0200 (-2.34%)

After-hours: May 6, 2026, 4:04 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Biotechnology (Startups)	285.76K	1.50M	583.23K	-	-
Biotechnology (Startups) Growth	-80.98%	157.63%	-	-	-
Total	285.76K	1.50M	583.23K	-	-
Total Growth	-80.98%	157.63%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	285.76K	1.50M	583.23K	-	-
United States Growth	-80.98%	157.63%	-	-	-
Total	285.76K	1.50M	583.23K	-	-
Total Growth	-80.98%	157.63%	-	-	-

Source: S&P Global Market Intelligence.